CYP26B1 and neoplasm: CYP26B1 negative/weak/moderate expressing tumours when compared with CYP26B1 strongly expressing tumours also showed a highly significant association with survival (HR = 1.948, 95%CI = 1.366–2.777, χ2 = 14.149, p<0.001).